MIM
CTVA icon

MetLife Investment Management’s Corteva CTVA Stock Holding History

MetLife Investment Management’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
153,063
-4,148
-3% -$333K 0.06% 319
2026
Q1 		$13.2M Sell
157,211
-4,913
-3% -$370K 0.07% 287
2025
Q4 		$10.9M Sell
162,124
-6,454
-4% -$417K 0.05% 331
2025
Q3 		$11.4M Sell
168,578
-5,271
-3% -$382K 0.05% 324
2025
Q2 		$13M Sell
173,849
-4,249
-2% -$283K 0.08% 245
2025
Q1 		$11.2M Sell
178,098
-4,026
-2% -$249K 0.06% 302
2024
Q4 		$10.4M Buy
182,124
+1,998
+1% +$118K 0.06% 253
2024
Q3 		$10.6M Sell
180,126
-5,820
-3% -$318K 0.06% 248
2024
Q2 		$10M Buy
185,946
+21,559
+13% +$1.19M 0.06% 244
2024
Q1 		$9.48M Sell
164,387
-6,854
-4% -$354K 0.06% 243
2023
Q4 		$8.21M Sell
171,241
-4,384
-2% -$209K 0.06% 265
2023
Q3 		$8.98M Sell
175,625
-4,852
-3% -$257K 0.07% 226
2023
Q2 		$10.3M Sell
180,477
-3,529
-2% -$206K 0.08% 210
2023
Q1 		$11.1M Sell
184,006
-2,606
-1% -$159K 0.08% 191
2022
Q4 		$11M Sell
186,612
-4,248
-2% -$269K 0.08% 192
2022
Q3 		$10.9M Sell
190,860
-4,115
-2% -$240K 0.09% 177
2022
Q2 		$10.6M Sell
194,975
-2,895
-1% -$168K 0.08% 191
2022
Q1 		$11.4M Buy
197,870
+36,824
+23% +$1.88M 0.07% 204
2021
Q4 		$7.61M Sell
161,046
-4,777
-3% -$218K 0.06% 257
2021
Q3 		$6.98M Sell
165,823
-5,070
-3% -$219K 0.06% 256
2021
Q2 		$7.58M Sell
170,893
-6,415
-4% -$296K 0.07% 246
2021
Q1 		$8.27M Sell
177,308
-3,623
-2% -$160K 0.08% 227
2020
Q4 		$7.01M Sell
180,931
-8,863
-5% -$317K 0.07% 254
2020
Q3 		$5.47M Sell
189,794
-5,931
-3% -$167K 0.06% 297
2020
Q2 		$5.24M Buy
195,725
+2,815
+1% +$73.3K 0.06% 295
2020
Q1 		$4.53M Sell
192,910
-5,902
-3% -$162K 0.06% 285
2019
Q4 		$5.88M Sell
198,812
-4,989
-2% -$132K 0.06% 293
2019
Q3 		$5.71M Sell
203,801
-2,601
-1% -$75.2K 0.06% 289
2019
Q2 		$6.1M Buy
+206,402
New +$5.55M 0.07% 272

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

MetLife Investment Management's CTVA Position: Q2 2026 in Review

MetLife Investment Management reduced its Corteva (CTVA) stake by 2.6% in Q2 2026, selling an estimated $333K and leaving 153,063 shares worth $13M. The position accounts for 0.06% of the portfolio, ranked #319.

MetLife Investment Management first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $13.2M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • MetLife Investment Management held 153,063 shares of Corteva worth $13M as of Q2 2026.
  • MetLife Investment Management sold 4,148 Corteva shares in Q2 2026, an estimated $333K.
  • Corteva made up 0.06% of MetLife Investment Management's portfolio in Q2 2026, its #319 holding.
  • MetLife Investment Management first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
  • MetLife Investment Management's Corteva position peaked at $13.2M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.